GHK-Cu is the specific compound: glycyl-L-histidyl-L-lysine complexed with a copper ion
The standard protocol combines daily BPC-157 at 0.25 to 0.5 mg with TB-500 at 5 mg weekly during the loading phase, typically split into 2.5 mg doses twice weekly
To Ciprofloxacin 0.3% W/v & Dexamethasone 0.1% W/v AGROSIP EYE / EAR DROP - CIPROFLOXACIN (0.3% W/V) AROLUB DS EYE DROP - Carboxymethylcellulose (1% w/v AROLUB EYE DROP - Carboxymethylcellulose (0.5% w/v) ATROCINE EYE DROP - Atropin Sulphate Ip (0.01% W/v) + Stabilized Oxychloo Complex (0.005% W/v) BIMROST EYE DROP - BIMATOPROST 0.03% w/v, STERILE AQUEOUS BASE
CagriSema still shows substantial, clinically meaningful weight loss, and the GLP-1 + amylin combination remains a highly interesting biological strategy
Antidepressant behavioral effects
Fatigue and Dizziness General weakness, dizziness, and loss of energy are frequently reported, particularly during early dose titration